YOUR BUSINESS AUTHORITY
Springfield, MO
Johnson & Johnson is selling its remaining stake in Kenvue, the maker of Tylenol and Band-Aids.
Johnson & Johnson's roughly 9.5% stake in Kenvue is being sold to Goldman Sachs and JPMorgan in a debt-for-equity exchange valued at $3.75 billion.
The banks plan to sell the roughly 189.3 million shares.
Read more from Quartz.
Project work in Springfield corridor will continue into 2031.
Thanksgiving staple recalled at Costco
HBA of Greater Springfield executive officer to retire
Warren Buffett donates $5.5B worth of Berkshire Hathaway shares
Transportation officials discuss $471M Forward 44 initiative
Monday Morning Business Leads: Nov. 16, 2026
Ozarks Farm Stop remains open after car crashes into building
Letter to the Editor: No half-baked cake for our kids. No half-baked school grades, either.